Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neuraxis (NRXS) Shares Outstanding (Weighted Average) (2022 - 2025)

Historic Shares Outstanding (Weighted Average) for Neuraxis (NRXS) over the last 4 years, with Q3 2025 value amounting to $9.9 million.

  • Neuraxis' Shares Outstanding (Weighted Average) rose 3772.59% to $9.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.9 million, marking a year-over-year increase of 3772.59%. This contributed to the annual value of $6.9 million for FY2024, which is 11273.64% up from last year.
  • Latest data reveals that Neuraxis reported Shares Outstanding (Weighted Average) of $9.9 million as of Q3 2025, which was up 3772.59% from $8.5 million recorded in Q2 2025.
  • In the past 5 years, Neuraxis' Shares Outstanding (Weighted Average) ranged from a high of $9.9 million in Q3 2025 and a low of $2.0 million during Q2 2022
  • Its 4-year average for Shares Outstanding (Weighted Average) is $5.0 million, with a median of $5.1 million in 2023.
  • As far as peak fluctuations go, Neuraxis' Shares Outstanding (Weighted Average) soared by 168.87% in 2023, and later surged by 24547.64% in 2024.
  • Over the past 4 years, Neuraxis' Shares Outstanding (Weighted Average) (Quarter) stood at $2.0 million in 2022, then soared by 62.35% to $3.3 million in 2023, then surged by 112.74% to $6.9 million in 2024, then surged by 42.77% to $9.9 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $9.9 million in Q3 2025, compared to $8.5 million in Q2 2025 and $7.5 million in Q1 2025.